SCHEMBL574598

SCHEMBL574598

CCCCCSC(O)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.50
GPR84 Q9NQS5 7/20 0.47
FFAR1 O14842 2/20 0.47
MAPT P10636 2/20 0.45
GMNN O75496 1/20 0.45
TP53 P04637 1/20 0.45
POLB P06746 1/20 0.45
THRB P10828 1/20 0.45
CYP2C9 P11712 1/20 0.45
BLM P54132 1/20 0.45
HSD17B10 Q99714 1/20 0.45
CES2 O00748 1/20 0.41
LCK P06239 1/20 0.41
PPARD Q03181 1/20 0.41
ZDHHC20 Q5W0Z9 1/20 0.41
ZDHHC2 Q9UIJ5 1/20 0.41
AKR1B1 P15121 1/20 0.39
CA2 P00918 1/20 0.39
MAPK1 P28482 1/20 0.39
FFAR4 Q5NUL3 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29095829 0.98 EPHX1 (0.53) EPHX1GPR84FFAR1MAPTGMNN
SCHEMBL11600198 0.98 EPHX1 (0.53) EPHX1GPR84FFAR1MAPTGMNN
SCHEMBL197825 0.98 EPHX1 (0.53) EPHX1GPR84FFAR1MAPTGMNN
SCHEMBL9833640 0.98 EPHX1 (0.53) EPHX1GPR84FFAR1MAPTGMNN
SCHEMBL1405573 0.98 EPHX1 (0.53) EPHX1GPR84FFAR1MAPTGMNN
SCHEMBL1423545 0.98 EPHX1 (0.53) EPHX1GPR84FFAR1MAPTGMNN
SCHEMBL11600053 0.98 EPHX1 (0.53) EPHX1GPR84FFAR1MAPTGMNN
SCHEMBL36143 0.98 EPHX1 (0.53) EPHX1GPR84FFAR1MAPTGMNN
SCHEMBL1891776 0.98 EPHX1 (0.53) EPHX1GPR84FFAR1MAPTGMNN
SCHEMBL625100 0.98 EPHX1 (0.53) EPHX1GPR84FFAR1MAPTGMNN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4555580-A FROM PHENYLTHIOGLYCOLIC ACIDS BAYER AKTIENGESELLSCHAFT (DE) 1985-11-26 US claimed
US-12577373-B2 Carbodiimide composition, curing agent composition, coating composition and resin cured product ASAHI KASEI KABUSHIKI KAISHA (JP) 2026-03-17 US disclosed
US-20230135772-A1 CARBODIIMIDE COMPOSITION, CURING AGENT COMPOSITION, COATING COMPOSITION AND RESIN CURED PRODUCT ASAHI KASEI KABUSHIKI KAISHA (JP) 2023-05-04 US disclosed
EP-4130154-A1 CARBODIIMIDE COMPOSITION, HARDENER COMPOSITION, COATING COMPOSITION, AND CURED RESIN OBJECT Asahi Kasei Kabushiki Kaisha (JP) 2023-02-08 EP disclosed
CN-115190901-A Carbodiimide composition, curing agent composition, coating composition, and resin cured product 旭化成株式会社 2022-10-14 CN disclosed
EP-3480285-B1 LUBRICATING COMPOSITION ADEKA CORP (JP) 2022-08-10 EP disclosed
CN-109415646-B Lubricating composition and engine oil composition containing same 株式会社ADEKA 2022-06-17 CN disclosed
US-11248187-B2 Lubricant additive composition, lubricating composition containing same and engine oil composition consisting of lubricating composition ADEKA CORPORATION (JP) 2022-02-15 US disclosed
US-20210253973-A1 LUBRICANT ADDITIVE COMPOSITION, LUBRICATING COMPOSITION CONTAINING SAME AND ENGINE OIL COMPOSITION CONSISTING OF LUBRICATING COMPOSITION ADEKA CORPORATION (JP) 2021-08-19 US disclosed
WO-2021149323-A1 LUBRICATING OIL COMPOSITION, AND LUBRICATING OIL COMPOSITION FOR INTERNAL COMBUSTION ENGINES DIC株式会社 2021-07-29 WO disclosed
US-6245725-B1 MIXTURE OF SYMMETRICAL AND ASYMMETRICAL SULFURIZED OXYMOLYBDENUM DITHIOCARBAMATES ALONG WITH PHENOLIC OR AMINE ANTIOXIDANT ASAHI DENKA KOGYO K.K. (JP) 2001-06-12 US disclosed
EP-1088882-A1 Lubricating compositions comprising a molybdenum-containing amine compound ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 2001-04-04 EP disclosed
EP-1041135-A1 Lubricating composition for diesel engines ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 2000-10-04 EP disclosed
EP-1013749-A2 Lubricating compositions ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 2000-06-28 EP disclosed
US-4863622-A THIOFATTY ACID ESTER OR FATTY ACID THIO AMINE PENNZOIL PRODUCTS COMPANY (US) 1989-09-05 US disclosed
EP-0243501-A1 CURABLE COMPOSITION AND METHOD FOR MOLDING IT SHOWA DENKO KABUSHIKI KAISHA (JP) 1987-11-04 EP disclosed
US-4652660-A OXIDATION BAYER AKTIENGESELLSCHAFT (DE) 1987-03-24 US disclosed
US-4555580-A FROM PHENYLTHIOGLYCOLIC ACIDS BAYER AKTIENGESELLSCHAFT (DE) 1985-11-26 US disclosed
US-4260778-A Process for the preparation of thioindigo compounds BAYER AKTIENGESELLSCHAFT (DE) 1981-04-07 US disclosed
US-RE29523-E Olefinic polymers stabilized with thioacyl trivalent phosphorus compounds BORG-WARNER CORPORATION (US) 1978-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12577373-B2 Carbodiimide composition, curing agent composition, coating composition and resin cured product CD38, PARP9, MCCC2 EPHX1 2661/4885GPR84 1157/4885FFAR1 1380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.